MedTrace Logo

Stopping Cavities Study: Diammine Silver Fluoride

NCT02536040 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 66

Last updated 2020-01-23

Study results available
· View outcomes & findings →

Summary

This study is being conducted to test whether the use of diammine silver fluoride (also called silver diamine fluoride) hardens the cavity sufficiently so that it arrests.

Conditions

  • Dental Caries

Interventions

DRUG

38% diammine silver fluoride

treatment of cavity with study agent

OTHER

Water

Fluoride free, distilled water

Sponsors & Collaborators

  • Advantage Dental Services, LLC

    lead INDUSTRY

Principal Investigators

  • Peter Milgrom, DDS · Advantage Dental Plans

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
24 Months
Max Age
60 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2016-07-31
Completion
2016-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02536040 on ClinicalTrials.gov